Skip to main content
Elsevier
View Cart

Biophysical Characterization of Proteins in Developing Biopharmaceuticals

  • 2nd Edition - September 1, 2019
  • Latest edition
  • Editors: Damian J. Houde, Steven A. Berkowitz
  • Language: English

Biophysical Characterization of Proteins in Developing Biopharmaceuticals, Second Edition, presents the latest on the analysis and characterization of the higher-order structure… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

Biophysical Characterization of Proteins in Developing Biopharmaceuticals, Second Edition, presents the latest on the analysis and characterization of the higher-order structure (HOS) or conformation of protein based drugs. Starting from the very basics of protein structure, this book explains the best way to achieve this goal using key methods commonly employed in the biopharmaceutical industry. This book will help today’s industrial scientists plan a career in this industry and successfully implement these biophysical methodologies. This updated edition has been fully revised, with new chapters focusing on the use of chromatography and electrophoresis and the biophysical characterization of very large biopharmaceuticals.

In addition, best practices of applying statistical analysis to biophysical characterization data is included, along with practical issues associated with the concept of a biopharmaceutical’s developability and the technical decision-making process needed when dealing with biophysical characterization data.

Key features

  • Presents basic protein characterization methods and tools applicable to (bio)pharmaceutical research and development
  • Highlights the capabilities and limitations of each technique
  • Discusses the underlining science of each tool
  • Empowers industrial biophysical chemists by providing a roadmap for applying biophysical tools
  • Outlines the needs for new characterization and analytical tools in the biopharmaceutical industry

Readership

Researchers in academia and corporate laboratories who develop new instrumental methods for characterisation of proteins in general and biopharmaceutical proteins specifically; researchers in industry who develop these proteins and need characterisation methods

Table of contents

I: Proteins and Biophysical Characterization in the Biopharmaceutical Industry

1. The Complexity of Protein Structure and the Challenges it Poses in Developing Biopharmaceuticals

2. Biophysical Characterization and Its Role in the Biopharmaceutical Industry

3. Biopharmaceutical Industry's Biophysical Toolbox

II: The Selected Biophysical Tools in the Biopharmaceutical Industry

4. An Introduction and Hierarchical Organization of the Biophysical Tool

5. The Value of UV, Fluorescence, and FTIR Spectroscopy in Biopharmaceutical Development

6. Circular Dichroism Spectroscopy for Protein Characterization: Biopharmaceutical Applications

7. Size-Exclusion Chromatograph (SEC) in Biopharmaceutical Process Development

8. Scattering Techniques for the Characterization of Biopharmaceuticals

9. Characterizing Biopharmaceuticals using Analytical Ultracentrifugation

10. Sub-visible and Visible Particle Analysis in Biopharmaceutical Research and Development

11. Differential Scanning Calorimetry in the Biopharmaceutical Sciences

12. Biophysical Mass Spectrometry for Biopharmaceutical Process Development: Focus on Hydrogen/Deuterium Exchange

13. One- and Two-Dimensional NMR Techniques for Biopharmaceuticals

14. Use of Chromatography and Electrophoresis for indirectly assessing Biophysical Characterization

III: Concluding Remarks on the Biophysical Characterization of Biopharmaceuticals

15. Biophysically Characterization of very large Biopharmaceuticals

16. Statistical Analysis of Biophysical Characterization Data

17. Biopharmaceutical Developability

18. Technical Decision-making dealing with Biophysical Characterization Data

19. Biophysical Characterization: An Integral Part of the "Totality of the Evidence" Concept

Product details

  • Edition: 2
  • Latest edition
  • Published: November 18, 2019
  • Language: English

About the editors

DH

Damian J. Houde

Damian J. Houde is Professor at the Department of Chemistry and Chemical Biology at the Northeastern University in Boston, MA. He teaches undergraduate and graduate level chemistry, biochemistry courses, and bioanalytical biochemistry. Further he is scientist, analytical development at Biogen Idec, Inc. in Cambridge, MA. He performs detailed biochemical and biophysical characterization of protein biopharmaceuticals (primarily monoclonal antibodies and Fc-fusion proteins) for structure activity relationship studies, investigates the conformation, dynamics, and interactions (epitope mapping) of protein biopharmaceuticals, with hydrogen-deuterium exchange mass spectrometry, assesses, develops, and evaluates new biochemical and biophysical protein characterization tools, coordinates and manages external academic (Northeastern University and University of Mass at Amherst) and internal research collaborations, manages and maintains mass spectrometry instrumentation, and conducts method transfers to QC. In 2009 he received the Douglas and Irena DeVivo Award (Northeastern University), in 2008 the Biogen IDEC Technology Investment Award, in 2008 the Biogen IDEC Technology Investment Award, Outstanding presentation, and in 2007 the Biogen IDEC Technology Investment Award
Affiliations and expertise
Relay Therapeutics, Cambridge, MA, USA and Department of Chemistry and Chemical Biology at the Northeastern University, Boston, MA, USA

SB

Steven A. Berkowitz

Steven A. Berkowitz is a principal investigator in the department of analytical development at Biogen Idec, Inc. in Cambridge MA. His technical areas of expertise are concentrated in the separation sciences and the physical sciences associated with the characterization of biopolymers and synthetic polymers where he has over 40 peer reviewed publication and has presented numerous talks and posters at a wide range of technical meetings. Much of Dr. Berkowitz’s work has centered on assessing the physico-chemical properties, micro-heterogeneity and aggregation properties of biopharmaceuticals using light scattering, analytical ultracentrifugation, chromatography, electrophoresis, and various forms of spectroscopy. His present responsibilities are now focused on providing biophysical information on the higher-order structure and structural dynamics of biopharmaceuticals and the development and evaluation of analytical tools such as H/DX-MS and NMR to support this area.

Dr. Berkowitz received a B.S. degree in Biology from Fairleigh Dickinson University and a Ph.D. degree in Biochemistry from New York University. He then spent several years as a post-doctoral fellow at Yale University and the NIH. After his post-doctoral work Dr. Berkowitz held various positions at Celanese Research Company, J.T. Baker, and Lederle Laboratories before taking his present position at Biogen Idec.

Affiliations and expertise
Consultant, Sudbury, MA, USA

View book on ScienceDirect

Read Biophysical Characterization of Proteins in Developing Biopharmaceuticals on ScienceDirect